MOACM
LEGN icon

Mutual of America Capital Management’s Legend Biotech LEGN Stock Holding History

Mutual of America Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.5M Buy
138,046
+57,683
+72% +$1.1M 0.03% 669
2025
Q4 		$1.75M Sell
80,363
-2,153
-3% -$61.7K 0.02% 856
2025
Q3 		$2.69M Buy
+82,516
New +$3.05M 0.03% 697

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mutual of America Capital Management's LEGN Position: Q1 2026 in Review

Mutual of America Capital Management increased its Legend Biotech (LEGN) stake by 72% in Q1 2026, buying an estimated $1.1M and bringing the position to 138,046 shares worth $2.5M. The position accounts for 0.03% of the portfolio, ranked #669.

Mutual of America Capital Management first reported a position in LEGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.69M in Q3 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Mutual of America Capital Management held 138,046 shares of Legend Biotech worth $2.5M as of Q1 2026.
  • Mutual of America Capital Management bought 57,683 Legend Biotech shares in Q1 2026, an estimated $1.1M.
  • Legend Biotech made up 0.03% of Mutual of America Capital Management's portfolio in Q1 2026, its #669 holding.
  • Mutual of America Capital Management first reported a position in Legend Biotech in Q3 2025 and has held it in 3 quarters since.
  • Mutual of America Capital Management's Legend Biotech position peaked at $2.69M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.